JenaValve Technology Revenue and Competitors



Total Funding

Estimated Revenue & Valuation

  • JenaValve Technology's estimated annual revenue is currently $56.8M per year.(i)
  • JenaValve Technology's estimated revenue per employee is $381,133
  • JenaValve Technology's total funding is $199.1M.

Employee Data

  • JenaValve Technology has 149 Employees.(i)
  • JenaValve Technology grew their employee count by 9% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
Add Company

JenaValve Technology, Inc., with locations in Irvine, Calif., Leeds, U.K. and Munich, Germany, develops and manufactures transcatheter aortic valve replacement (TAVR) systems to treat patients suffering from aortic valve disease. The Company is in clinical development of its next-generation transfemoral TAVR system in both the U.S. and CE mark countries for treating patients with aortic stenosis and/or aortic regurgitation. In addition to Bain Capital Life Sciences, JenaValve is backed by European and Asian investors, including Andera Partners (formerly Edmond de Rothschild Investment Partners), Gimv (Euronext: GIMB), Legend Capital, NeoMed Management, RMM, Valiance Life Sciences and VI Partners. Additional information is available at



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





JenaValve Technology's People

Manager, Administrative ServicesReveal Email/Phone
West Region Therapy SpecialistReveal Email/Phone
Director Regulatory AffairsReveal Email/Phone
Principal Quality EngineerReveal Email/Phone
Senior Project Manager, Regulatory AffairsReveal Email/Phone
Chief Medical OfficerReveal Email/Phone
Director, Strategy and Field OperationsReveal Email/Phone
Director, Program ManagementReveal Email/Phone
Director, Clinical AffairsReveal Email/Phone
Director, Quality AssuranceReveal Email/Phone

JenaValve Technology News

2022-04-19 - What Target Market Does Bioprosthetics Have? LeMaitre Vascular ...

... including new technologies, industry drivers, challenges, ... Inc., Edwards Lifesciences Corporation, JenaValve Technology GmbH.

2022-04-17 - Heart Valve Devices Market Size And Forecast | Abbott, CryoLife ...

... Boston Scientific, Edward Lifesciences, TTK HealthCare, JenaValve Technology, Medtronic, Neovasc, Sorin Group, Micro Interventional.

2022-04-06 - Heart Valve Repair and Replacement Devices Market to grow at a ...

... Boston Scientific Corp., Colibri Heart Valve LLC, Edwards Lifesciences Corp., JenaValve Technology Inc., LivaNova Plc, Medtronic Plc,...

2020-02-10 - JenaValve Finds $50M Funding

Irvine-based JenaValve Technology, which develops aortic valve replacements, said last week that it has raised $50M in a financing round. The funding was led by Bain Capital Life Sciences, and also included existing investors Andera Partners, Gimv, Legend Capital, NeoMed Management, RMM, Valianc ...

2020-02-07 - TAVR developer JenaValve nets $50M from Bain Capital Life Sciences

Heart valve maker JenaValve Technology has raised $50 million in new venture capital funding, not long after receiving a breakthrough device designation from the FDA for its transcatheter aortic valve replacement (TAVR) system. Sponsored by Agilent Technologies How would you like to win free b ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding